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Abstract
Survival motor neuron (SMN) protein deficiency causes the genetic neuromuscular
disorder spinal muscular atrophy (SMA), characterized by spinal cord motoneuron
degeneration. Since SMN protein level is critical to disease onset and severity, analysis of
the mechanisms involved in SMN stability is one of the central goals of SMA research.
Here, we describe the role of several members of the NF-κB pathway in regulating SMN in
motoneurons. NF-κB is one of the main regulators of motoneuron survival and
pharmacological inhibition of NF-κB pathway activity also induces mouse survival motor
neuron (Smn) protein decrease. Using a lentiviral-based shRNA approach to reduce the
expression of several members of NF-κB pathway, we observed that IKK and RelA
knockdown caused Smn reduction in mouse-cultured motoneurons whereas IKK or RelB
knockdown did not. Moreover, isolated motoneurons obtained from the severe SMA
mouse model showed reduced protein levels of several NF-κB members and RelA
phosphorylation. We describe the alteration of NF-κB pathway in SMA cells. In the
context of recent studies suggesting regulation of altered intracellular pathways as a future
pharmacological treatment of SMA, we propose the NF-κB pathway as a candidate in this
new therapeutic approach.
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Introduction
The NF-κB (nuclear factor–κB) intracellular pathway is involved in physiological processes
of the nervous system such as regulation of apoptosis, neurite outgrowth and synaptic
plasticity [1, 2, 3, 4]. A ubiquitously expressed transcription factor system, NF-κB consists of
homodimers and heterodimers of five structurally related proteins: RelA/p65, RelB, c-Rel,
p50 and p52, of which the p50/RelA heterodimer is the most abundant [5, 6]. In the absence
of stimuli, NF-κB homo- or heterodimers are present in the cytoplasm and form inactive
complexes with their inhibitors, the IκB (Inhibitor κB) protein family. When the pathway is
activated, phosphorylation of IκB induces p50/RelA release and translocation to the nucleus.
IκB is phosphorylated by the kinases of the inhibitor (IκB kinases), IKKα and IKKβ [7].
RelA can be phosphorylated at several sites inducing conformational changes which impact
RelA ubiquitination, stability and protein-protein interactions. Phosphorylated RelA in S536
has lower affinity for IκBα, which results in increased nuclear translocation and accumulation
of p65 [8]. In the nervous system, NF-κB activation regulates genes and proteins involved in
several neuronal processes, such as Bcl-x  [9], BDNF [10], NCAM [11] and Cu/Zn-SOD [12
]. The canonical NF-κB activation regulates neuronal and motoneuron (MN) cell survival [13,
14], and evidences are emerging about its role in neurodegenerative disorders and neuronal
injury [6, 15]. Based on NF-κB functions, it has been suggested that pharmacological
regulation of NF-κB activity could be beneficial in some of these diseases [16].
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder characterized by the
degeneration of MNs in the anterior horn of the spinal cord, together with muscular atrophy
and weakness. SMA results from survival motor neuron (SMN) protein deficiency. In
humans, SMN is encoded by the SMN gene, which is present in multiple copies, one
telomeric copy of SMN1 and several centromeric copies of SMN2. SMA is caused by
homozygous disruption of the SMN1 gene by deletion, conversion, or mutation [17]. SMN1
expresses a full-length transcript, and SMN2 expresses primarily a truncated isoform that is
unable to compensate SMN1 deficiency. SMN protein level is critical to disease onset and
severity and is determined in part by the SMN2 copy numbers [18]. One of the central
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objectives of developing SMA therapeutics is to identify mechanisms that increase SMN
protein levels [19], which require a basic understanding of SMN protein regulation. In the
present study, we characterized the contribution of several members of the NF-κB pathway in
regulating mouse survival motor neuron (Smn) protein level in cultured spinal cord MNs.
Pharmacological inhibition of NF-κB pathway activity induced Smn protein decrease. Using
a lentiviral-based short-hairpin RNA (shRNA) approach to reduce the expression of several
members of the NF-κB pathway, we observed that IKKα and RelA knockdown caused Smn
protein reduction whereas IKKβ or RelB knockdown did not. Isolated and cultured MNs from
severe SMA mouse model showed reduced protein levels in several members of NF-κB and
RelA phosphorylation. Our results suggest that NF-κB pathway activation regulates SMN
protein level in spinal cord MNs.
Materials and Methods
Mouse MN Isolation and Culture
AQ3
MN cultures were prepared from embryonic 12.5-day (E12.5) CD1 male and female mouse
spinal cords essentially as described [20, 21]. Isolated cells were pooled in a tube containing
culture medium and plated [21]. Cultured MNs enriched by Iodixanol were clearly identified
by morphological criteria. All of the procedures were in accordance with the Spanish Council
on Animal Care and approved by the University of Lleida Advisory Committee on Animal
Services.
Isolated MNs were plated in four-well tissue culture dishes (Nunc, Thermo Fisher Scientific)
in a density of 15,000 cells per well for survival and immunofluorescence experiments,
70,000 cells per well for western blot analysis and 300,000 cells per well for qRT-PCR.
Complete culture medium was Neurobasal (Gibco, Invitrogen) supplemented with B27
(Gibco, Invitrogen), horse serum (2% v/v), L-glutamine (0.5 mM), and 2-mercaptoethanol
(25 μM). Cells were plated and maintained with complete medium containing a cocktail of
recombinant NTFs: 1 ng/ml brain-derived neurotrophic factor, 10 ng/ml glial cell line-derived
neurotrophic factor, 10 ng/ml cardiotrophin-1, and 10 ng/ml hepatocyte growth factor
(Peprotech).
Survival evaluation was performed using photomicrographs of different microscopic areas
from each dish (4 central areas per well, 3 wells for each condition), and counting the number
of large-phase bright neurons with long neurite processes present in the photomicrographs.
Survival was expressed as the percentage of cells counted 3 days after treatment with respect
to the initial value (3 h after plating, 100%).
SMA Animals
Severe SMA mice FVB.Cg-Tg(SMN2) Smn1 /J were kindly provided by Dr.89Ahmb tm1Msd
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Josep E Esquerda (IRBLLEIDA-Universitat de Lleida). Heterozygous animals were crossed
to obtain homozygous Smn ;SMN2  (mutSMA). Littermates mutSMA and
Smn ;SMN2  (WT) were used for the experiments. For MN purification, E13 embryos
were removed from the uterus and a piece was snipped from the head for genotyping. The
REDExtract-N-Amp Tissue PCR Kit (Sigma) was used for genomic DNA extraction and
polymerase chain reaction setup, with the following primers: WT forward 5′
CTCCGGATATTGGGATTG 3′, SMA reverse 5′ GGTAACGCCAGGGTTTTCC 3′ and WT
reverse 5′TTTCTTCTGGCTGTGCCTTT 3′. After genotyping, WT and mutSMA embryos
were submitted to spinal cord dissection, MN isolation and culture as described above.
Immunofluorescence of RelA Nuclear Translocation
The determination of cellular localization of RelA into MNs was performed as previously
described [13]. Briefly, cultures were fixed 5 days after lentivirus transfection in 4%
paraformaldehyde and 100% methanol, incubated overnight at 4 °C with a polyclonal anti-
RelA antibody (1:100; Santa Cruz Biotechnology), and consecutively with an anti-rabbit
secondary antibody conjugated with Alexa Fluor 488 (Invitrogen). Hoechst 33,258 staining
was used for nuclear localization. The images were obtained using a FluoView 500 Olympus
confocal microscope.
Western Blot Analysis
Western blot analysis was performed as previously described [22]. Cells were rinsed in ice-
cold PBS (pH 7.2) after stimulation or lentiviral transduction. Total cell lysates were
collected and resolved in SDS-polyacrylamide gels and transferred onto polyvinylidene
difluoride Immobilon-P transfer membrane filters (Millipore, Billerica, MA) using an
Amersham Biosciences (Piscataway, NJ, USA) semidry Trans-Blot according to
manufacturer instructions. Membranes were blotted with the specific antibodies anti-RelA
(1:1000), anti-phosphoRelA (Ser536) (1:1000) or anti-CREB (1:1000) from Cell Signaling
Technology; anti-SMN (1:5000) from BD Transduction Laboratories; anti-IKKβ (1:1000) or
anti-IKKα (1:1000) from Calbiochem or anti-RelB (1:1000) (C-19) from Santa Cruz,
following the instructions of the providers. To control the specific protein content per lane,
unless stated otherwise, the membranes were re-probed with a monoclonal anti-α-tubulin
(Tub) antibody (1:50,000, Sigma), as described by the provider. Blots were developed using
the Super Signal chemiluminescent substrate (Pierce, Rockford, IL, USA) or the ECL
Advance Western Blotting detection kit (Amersham Biosciences).
NF-ĸB inhibitor SN50, the inactive control peptide SN50M, and the proteasome inhibitor
MG132 were purchased from Calbiochem.
RNA Isolation and Quantitative RT-PCR
For qRT-PCR analysis, MNs (300,000 cells/condition) were plated and transduced with
−/− +/+
+/+ +/+
e.Proofing
http://eproofing.springer.com/journals/printpage.php?token=J0m60B74dnf9wtTOGFC5pGgw5sVvEn9PQGffCo3uKsE[08/08/2017 13:02:52]
shRNA. Total RNA was extracted using the NucleoSpin® RNA columns (Machery-Nagel,
Düren, Germany) according to manufacturer instructions. One microgram of total RNA from
each condition was reverse-transcribed to complementary (cDNA), and 25 ng was used for
each individual RT-PCR reaction. The assays were performed in a CFX96 Real-Time System
(Bio-Rad) using iTaq™ Universal SYBR® Green Supermix from Bio-Rad. Real-Time was
performed using SMN-specific primers: SMN exon 1-forward (5′-
GATGATTCTGACATTTGGGATG-3′) and SMN Exon 2-reverse (5′-
TGGCTTATCTGGAGTTTCAGAA-3′) and specific primers of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH): forward (5′-TGCACCACCAACTGCTTAG-3′) and reverse (5′-
GGATGCAGGGATGATGTTC-3′) as internal control. Quantification was completed using
iCycler IQ real-time detection system software (version 2.3, Bio-Rad). Relative expression
ratios were calculated on the basis of ΔCp values with efficiency correction based on multiple
samples.
Plasmids and Production of Lentiviral Particles
Lentiviral-based vectors for RNA interference-mediated gene silencing (FSVi) were
performed as described [23]. FSVi consisted of a U6 promoter for expression of short-hairpin
RNAs (shRNAs) and the Venus variant of green fluorescent protein (GFP) under the control
of an SV40 promoter to monitor transduction efficiency. Lentiviruses were propagated in
HEK293T cells using the polyethylenimine (PEI, Sigma) cell transfection method. Twenty
micrograms of the above plasmids containing the shRNAs or the empty vector (FSV), 13 μg
of pSPAX2 and 7 μg of pM2G were transfected to HEK293T cultures. Cells were allowed to
produce lentivirus for 4 days. Then, the medium was centrifuged at 1200×g for 5 min and the
supernatant was filtered using a 45 μm filter. The medium containing the lentiviruses was
stored at 4 °C. Biological titres of the viral preparations, expressed as the number of
transducing units per ml (TU/ml), were determined by transducing HEK293T cells in limiting
dilutions. After 48 h, the percentage of GFP-positive cells was measured and viruses at
4 × 10 –1 × 10  TU/ml were used for the experiments. For lentiviral transduction, MNs were
plated in four-well dishes and after 2 h, the medium containing lentivirus (2 TU/cell) was
added. The medium was changed 20 h later and infection efficiency was monitored in each
experiment by direct-counting GFP-positive cells. The frequency of infection rose 99%. RNA
interference efficiency was monitored by western blot analysis using specific antibodies.
The following sequences were used for generation of shRNAs: IKKα: 5′-
CAGGCTCTTTCAGGGCAT-3′; IKKβ: 5′-GCTGCACATTTGAATCTGTAT-3′; RelA: 5′-
AGATCTTGAGCTCGGCAGTG-3′; RelB: 5′-GCATGCGCTTCCGCTACGAGT-3′; CREB:
5′-GTGGATAGTGTAACTGATT-3′. shRNAs of IKKs and RelA have been previously
described [24].
Statistical Analysis
All experiments were performed at least three times. Values were expressed as mean ± SEM.
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The data obtained from the independent experiments were used for statistical analysis.
We used one-way analysis of variance (ANOVA) to assess differences between groups for
variable treatment. If the ANOVA test was statistically significant, we performed “post-hoc”
pairwise comparisons using the Bonferroni test. We used the Student t test to compare the
means of two groups. P values < 0.05 were considered significant.
Results
NF-κB Inhibitor SN50 Reduces Smn Protein Level in Cultured Spinal
Cord MNs
Previous studies have shown that NF-κB pathway contributes to neurotrophic factor (NTF)-
mediated MN survival [13]. To further investigate the role of NF-κB in MN physiology and
Smn regulation, we pharmacologically inhibited the NF-κB pathway using the SN50 inhibitor
peptide and analysed Smn levels in protein extracts of cultured MNs. SN50, a cell-permeable
peptide that blocks the nuclear localization sequence of p50, inhibits the translocation of
NF-κB active complex to the nucleus [25]. MNs were isolated from E12.5 mouse embryos
and maintained in the presence of the NTF cocktail (1 ng/ml BDNF, 10 ng/ml GDNF,
10 ng/ml CNTF and 10 ng/ml HGF). Cultures were left untreated (control) or treated with
30 μM SN50 or its inactive control peptide, SN50M. Two days later, cell extracts were
collected and analysed by western blot using a specific antibody against Smn (Fig. 1). The
presence of the NF-κB inhibitor in the culture medium significantly decreased Smn protein
level, whereas its negative control SN50M did not induce significant changes in Smn
(0.42 ± 0.1 SN50 vs control p < 0.05 and 0.86 ± 0.07 SN50M vs control). Survival evaluation
after 2 days of treatment showed a significant decrease from baseline in the number of MNs
in SN50-supplemented cultures, compared with SN50M (16.1 ± 1.3% SN50 and 82.3 ± 4.1%
SN50M, p < 0.0001) and an increase of apoptotic nuclei (data not shown). These results
indicate that the pharmacological inhibition of the NF-κB pathway reduces survival and Smn
protein level in cultured mouse spinal cord MNs.
Fig. 1
Effect of NF-κB inhibitor SN50 on Smn protein level. In the text and figure legends the labels
"a, b, c" are lower case, but in the images are capital. Is it correct? a Representative
Western blots for Smn and α-tubulin (loading control) in protein extracts of MNs treated
during 2 days with the NF-κB inhibitor SN50 (30 μM) and its inactive control SN50M
(30 μM). Graph values indicate the expression of Smn vs tubulin and correspond to the
quantification of three independent experiments ± SEM (error bars). Asterisk indicates
significant differences using one-way ANOVA test and Bonferroni post hoc multiple
comparisons (p < 0.05). b MNs were cultured in the presence of SN50 (30 μM) or SN50M
(30 μM). Cell survival was evaluated 2 days after treatment. Graph values are the mean of the
percentage of cell survival for each condition from three independent experiments ± SEM.
Asterisk indicates significant differences using Student t test (p < 0.001)
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RelA, But Not RelB, Inhibition Causes Smn Reduction in MNs in the
Presence of NTFs
To determine whether the canonical or non-canonical NF-κB pathways are relevant in Smn
protein regulation in MNs, we analysed the effect of RelA or RelB knockdown. The
RelA/p50 heterodimer is activated in the canonical and RelB/p52 in the non-canonical
pathway [7]. Therefore, we used shRNA targeting specific sites of mouse RelA (shRelA) or
RelB (shRelB) sequences to block the canonical or non-canonical pathways, respectively [13
]. MNs were isolated from E12.5 mouse embryos and maintained in the presence of NTFs.
Two hours after plating, culture medium was changed and medium containing NTFs plus
lentivirus of shRelA or shRelB or shRNA empty vector (FSV) was added. Twenty hours
later, the lentivirus-containing medium was washed and replaced by fresh medium
supplemented with NTFs. Fluorescence microscopy of GFP-positive cells showed nearly
100% transduction (Fig. 2). After 5 days, western blot analysis of cultures transduced with
the lentivirus carrying the shRelA exhibited a significant reduction in Smn protein
(0.57 ± 0.03; p < 0.05) whereas cultures transduced with shRelB showed no change
(0.99 ± 0.06) (Fig. 2a, b, respectively). Control western blots of RelA or RelB protein
revealed significant reductions in both cases, under shRelA or shRelB conditions,
respectively. These results showed NF-κB pathway regulating Smn protein level by the
canonical pathway, but not by the non-canonical pathway.
Fig. 2
RelA, but not RelB, knockdown reduced Smn protein level in cultured spinal cord MNs.
Mouse MNs were transduced with lentivirus containing the shRelA, shRelB or empty vector
(FSV) constructs. a Representative microscopy images of 5-day shRelA- or FSV-transduced
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cells: phase contrast (top) and GFP (bottom). Total cell lysates were probed by western blot
with anti-SMN or anti-RelA antibodies and reprobed using an antibody against α-tubulin.
Graph values represent the expression of Smn vs α-tubulin and correspond to the
quantification of three independent experiments ± SEM. Asterisk indicates significant
differences using Student t test (p < 0.05). b Representative microscopy images of 5 days
shRelB- or FSV-transduced cells: phase contrast (top) and GFP (bottom). Total cell lysates
were probed by western blot with anti-SMN or anti-RelB antibodies and reprobed using an
antibody against α-tubulin. Graph values represent the expression of Smn vs α-tubulin and
correspond to the quantification of three independent experiments ± SEM
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Both IKKα and IKKβ Knockdown Prevent RelA Phosphorylation and
Nuclear Translocation in Cultured MNs
RelA phosphorylation and nuclear translocation is a key event in canonical NF-κB activation
and target gene regulation. To analyse the effect of IKKα or IKKβ reduction on RelA
phosphorylation and translocation to the nucleus, MNs were transduced with shIKKα,
shIKKβ or empty vector (FSV) or were left non-transduced (control). After 5 days, cultures
were submitted to western blot analysis using anti-phosphoRelA (pRelA) or anti-RelA
antibodies or were fixed to determine RelA localization by immunofluorescence using an
anti-RelA antibody. RelA phosphorylation was significantly reduced in shIKKα (0.66 ± 0.02,
p < 0.001) and shIKKβ (0.31 ± 0.05, p < 0.0001) cultures compared with the FSV control
(Fig. 3a). It was also evident that pRelA level was significantly reduced in shIKKβ compared
with shIKKα cultures (p < 0.001). However, no differences were observed in total RelA level,
indicating that the reduction of RelA phosphorylation was not due to RelA protein decrease.
Fig. 3
Effect of IKK knockdown on RelA phosphorylation and nuclear translocation. Mouse MNs
were transduced with lentivirus containing the shIKKα, shIKKβ or empty vector (FSV)
constructs. a Representative western blot for phospho-Ser536 RelA (pRelA) and total RelA in
protein extracts of 5-day transduced cultures. Membranes were reprobed using an antibody
against α-tubulin. Graph values represent the expression of p-RelA or RelA vs α-tubulin and
correspond to the quantification of three independent experiments ± SEM. b Five-day
transduced cells were fixed and immunofluorescence was performed using an anti-RelA
antibody. Representative confocal images of p65 (red) and Hoechst nuclear staining (blue).
Graph represents the percentage of cells with nuclear RelA in each condition and corresponds
to the quantification of three independent experiments ± SEM. In a and b, asterisks indicate
significant differences using one-way ANOVA test and Bonferroni’s post hoc multiple
comparisons (***p < 0.0001, **p < 0.001, *p < 0.01)
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In control cultures, immunofluorescent confocal images of cultured MNs using an anti-RelA
antibody showed RelA localization clearly distinguishable into the nucleus (Fig. 3b).
Hoechst33258 was used as a nuclear marker. We measured the percentage of MNs with
nuclear RelA in control, FSV, shIKKα and shIKKβ cultures. Cellular distribution showed a
reduced percentage of MNs with nuclear RelA in shIKKα (66.5 ± 1.6%) and shIKKβ
(37.1 ± 8.1%) conditions, compared to FSV (91.5 ± 0.2%; p < 0.01 and p < 0.0001,
respectively). No significant differences in nuclear RelA were observed in non-lentivirus
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treated (control) and FSV conditions (88.8 ± 2.2 and 91.5 ± 0.4%, respectively). These results
also indicate a decreased percentage of nuclear RelA in IKKβ knockdown cells, compared
with shIKKα cultures (p < 0.001), supporting the hypothesis that IKKβ is the main kinase
responsible for RelA phosphorylation.
Inhibiting IKKα Vs IKKβ has Opposite Effect on Smn Protein Level in
MNs
Because the activation of the canonical NF-κB pathway depends upon the phosphorylation
status of the two kinases IKKα and IKKβ, we analysed the effect of IKK knockdown on the
Smn level of cultured MNs. To this end, we produced lentivirus containing the shRNA
targeting specific sites of mouse IKKα (shIKKα) or IKKβ (shIKKβ), as previously described
[13]; MNs were isolated and transduced following the same protocol. After 5 days, cultures
transduced with shIKKα or shIKKβ exhibited a strong reduction in IKKα or IKKβ protein,
respectively, compared with the empty vector condition (FSV). Western blot analysis of
protein extracts of shIKKα condition showed a significant reduction in Smn protein
(0.62 ± 0.07, p < 0.001) compared to the FSV or non-transduced (control) conditions (Fig.
4a). To discard changes in Smn after lentiviral transduction, protein extracts from non-
transduced cultures were submitted to western blot; no differences were observed when
compared with the FSV condition. When cells were transduced with the shIKKβ, Smn protein
level was significantly increased (1.3 ± 0.13, p < 0.005) compared to the controls (Fig. 4a).
These findings demonstrated that both IKKα and IKKβ regulate Smn level in MNs.
Nevertheless, IKKα reduction decreases Smn level whereas IKKβ knockdown increases Smn
count.
Fig. 4
Smn protein and mRNA regulation by IKK knockdown. MNs were transduced with lentivirus
containing the shIKKα, shIKKβ, shIKKα + shIKKβ or empty vector (FSV) constructs. a
Protein extracts of 5-day transduced cells were submitted to western blot using anti-SMN,
anti-IKKα and anti-IKKβ antibodies. b Five-day FSV and shIKKα transduced cultures were
treated (12 h) with 2.5 μM MG132. Protein extracts were submitted to western blot using
anti-SMN and anti-IKKα antibodies. In a and b, membranes were reprobed with an anti-α-
tubulin antibody. Graph values represent the expression of Smn vs α-tubulin and correspond
to the quantification of 5 (a) or 3 (b) independent experiments ± SEM. Asterisks indicate
significant differences using one-way ANOVA test and Bonferroni’s post hoc multiple
comparisons (*p < 0.05). c Total RNA was extracted from 5-day FSV-, shIKKα- and non-
transduced cultures and reverse-transcribed to cDNA. Gapdh gene was used as a control.
Graph values are the mean of Smn gene expression for each from three independent
experiments ± SEM. Asterisks indicate significant differences using one-way ANOVA test
and Bonferroni’s post hoc multiple comparisons (*p < 0.05)
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Because IKKα and IKKβ knockdown produced opposite effects on Smn levels, we analysed
the effect of shIKKα and shIKKβ co-transduction on Smn protein level. Five days after,
shIKKα and shIKKβ co-transduction protein lysates were obtained and submitted to western
blot analysis (Fig. 4a). Results revealed that Smn protein was not significantly altered in co-
transduced cultures compared with FSV or non-transduced controls. However, Smn level in
the co-transduced condition (0.82 ± 0.08) was significantly reduced (p < 0.05) in comparison
with shIKKβ (1.03 ± 0.13). Therefore, IKKα knockdown clearly prevents Smn increase
caused by IKKβ reduction.
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To further analyse Smn regulation by IKKα knockdown, we evaluated the effect of
proteasome inhibition. Previous studies have shown that SMN degradation is mediated via
the ubiquitin/proteasome pathway in SMA patient-derived fibroblasts [26, 27]. Cells were
transduced with FSV or shIKKα. Five days after transduction, cultures were treated for 12 h
with 2.5 μM of the proteasome inhibitor MG132. Protein extracts were submitted to western
blot using the anti-SMN antibody. Under both FSV and shIKKα conditions, Smn protein
level was increased in MG132-treated cells compared with the non-treated FSV or shIKKα
condition (1.33 ± 0.09-fold induction and 1.13 ± 0.07-fold induction, respectively, p < 0.05)
(Fig. 4b). This result suggests the Smn decrease caused by IKKα knockdown occurs as a
result of the proteasome activity.
Next, to determine whether the Smn increase caused by IKKβ knockdown was associated
with activation of Smn gene expression, we quantified Smn messenger RNA (mRNA) by
quantitative RT-PCR (qRT-PCR). Gapdh gene was used as a control. Cultured MNs were
transduced with FSV or shIKKβ lentiviral constructs. After 4 days, total RNA was extracted
and reverse-transcribed to cDNA, used as a template to quantify Smn transcript level. IKKβ
reduction was related to an increase in Smn mRNA expression (2.17 ± 0.38-fold induction,
p < 0.05) compared with control conditions (non-transduced and FSV), showing that IKKβ
knockdown regulates Smn at the transcriptional level (Fig. 4c).
IKKα or IKKβ Knockdown Affects CREB Protein Levels in MNs
Previous evidence suggests that cAMP-response element-binding (CREB) may regulate SMN
expression [28]. In turn, NF-κB signalling pathway controls CREB protein level in MNs [13,
28]. In this context, we decided to analyse CREB protein level in IKK knockdown cultures.
MNs were isolated and transduced with empty vector (FSV) or shIKKα, shIKKβ or shIKKα
plus shIKKβ. Twenty-four hours after transduction, medium containing lentiviral particles
was replaced with fresh medium supplemented with NTFs. Five days later, cells were lysed
and protein extracts were submitted to western blot analysis. The CREB protein level was
significantly reduced in shIKKα-transduced MNs (0.66 ± 0.02, p < 0.001), compared to the
FSV control. In contrast, IKKβ knockdown significantly increased the level of CREB protein
(1.79 ± 0.1, p < 0.005), compared to FSV control. When cultures were co-transduced with
shIKKα plus shIKKβ, the level of CREB protein (0.59 ± 0.09, p < 0.05) was comparable to
that observed in shIKKα-only cultures (Fig. 5a). These results show that the IKK complex
regulates the intracellular level of the CREB protein with a pattern similar to that observed in
Smn experiments.
Fig. 5
CREB protein regulation by IKK knockdown. a MNs were transduced with lentivirus
containing the shIKKα, shIKKβ, shIKKα + shIKKβ or empty vector (FSV) constructs. Five
days after transduction, protein lysates were submitted to western blot using an anti-CREB
antibody. b MNs were transduced with shCREB or FSV and 5 days later, protein extracts
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were submitted to western blot analysis using an anti-SMN antibody. In a and b, membranes
were reprobed with an anti-α-tubulin antibody. Graph values represent the expression of
CREB or Smn vs α-tubulin and correspond to the quantification of three independent
experiments ± SEM. Asterisks in a indicate significant differences using one-way ANOVA
test and Bonferroni’s post hoc multiple comparisons (p < 0.005). Asterisk in b indicates
significant differences using Student t test (p < 0.05)
To analyse whether CREB reduction causes changes in Smn protein level, we generated
lentivirus shCREB, isolated the MNs, and transduced the cells with the empty vector (FSV)
or shCREB. After 24 h, the medium was replaced with NTF-supplemented medium and cells
were maintained in this medium for 5 days. To measure the level of Smn protein, total protein
extracts were submitted to western blot analysis. The Smn protein level was significantly
reduced in CREB knockdown condition (0.82 ± 0.02, p < 0.05), compared with the FSV
control (Fig. 5b). These experiments suggest that the CREB transcription factor regulates
Smn protein level in MNs.
NF-κB Levels in Cultured MNs Differ between Wild-Type and SMA
Mutant Mice
To analyse whether levels of NF-κB pathway proteins were altered in SMA-mutant MNs,
E13 embryos of SMA type I mice were genotyped and spinal cords of WT (Smn ;SMN2 )
and mutSMA (Smn ;SMN2 ) were dissected. MNs were isolated following the same
protocol described in the “Materials and Methods” section. Cells were maintained in the
presence of NTFs for 6 days before cell lysates were obtained. Western blot analysis of total
protein extracts demonstrated that IKKα and IKKβ were significantly reduced in mutSMA
+/+ +/+
−/− +/+
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(0.85 ± 0.03, p < 0.005; 0.67 ± 0.06, p < 0.005, respectively) compared to the WT condition
(Fig. 6a). A time-course experiment demonstrated that IKKα and IKKβ reduction was
maintained from day 2 to day 8 in culture (data not shown). The level of RelA protein
(0.92 ± 0.13) did not differ significantly from the WT control. Nevertheless, we observed that
RelA phosphorylation was reduced after 6 days in culture, compared to the WT control
(0.59 ± 0.07, p < 0.01) (Fig. 6b). Together, these results show that the protein level of some
members of the NF-κB pathway is reduced and RelA phosphorylation is compromised in
cultured SMA MNs.
Fig. 6
NF-κB members are modified in SMA-cultured mice spinal-cord MNs. WT and mutSMA
isolated MNs were cultured in the presence of NTFs. Six days later, protein extracts were
submitted to western blot analysis using the following antibodies: anti-IKKα, anti-IKKβ (a),
anti-RelA, anti-phosphoRelA (P-RelA) (b) and anti-SMN. Membranes were reprobed with an
anti-α-tubulin antibody as a loading control. Graph values represent the expression of IKKα,
IKKβ, RelA or P-RelA vs α-tubulin and correspond to the quantification of at least three
independent experiments ± SEM. Asterisks indicate significant differences using Student t
test (*p < 0.05, **p < 0.005)
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Discussion
In the present work, we show that the canonical NF-κB pathway regulates Smn protein in a
primary culture of isolated mouse embryonic MNs. Reducing protein levels of several
members of the NF-κB signalling pathway revealed that these proteins modulate Smn. RelA
knockdown was associated with a significant decrease in Smn, but RelB reduction was not.
The NF-κB pathway can be activated by two main routes: canonical (or classical) and non-
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canonical. The canonical pathway is characterized by the activation and translocation of
p50/RelA heterodimers to the nucleus, whereas the non-canonical pathway relies on
p52/RelB heterodimers [7]. It is known that RelA and RelB heterodimers regulate separate
subsets of NF-κB target genes and might therefore regulate diverse cellular functions [29, 30
]. Previous studies on MN survival describe this differential effect: RelA knockdown caused
MN cell death; RelB knockdown did not [13]. Our present results clearly indicate that
canonical NFκ-B pathway inhibition reduces Smn levels in cultured MNs, supporting the
involvement of this pathway in the regulation of Smn in these cells. This hypothesis is also
supported by the results observed after pharmacological inhibition of NF-κB using SN50, a
cell-permeable peptide that blocks the nuclear localization sequence of p50 and prevents its
nuclear translocation [25]: SN50 treatment clearly reduced Smn level in cultured MNs;
therefore, pharmacological and knockdown experiments have provided evidence that NF-κB
activation is involved in Smn stability in MNs.
Inhibition of IκB kinases regulates Smn differentially. Smn protein decreased with IKKα
knockdown and increased with IKKβ knockdown. IKKβ is the predominant kinase
responsible for IκBα and p105 phosphorylation [31]. In cultured MNs, we described a
significant reduction in RelA nuclear translocation and phosphorylation in IKKβ knockdown
compared with IKKα knockdown cells, supporting the predominant role of IKKβ in
activating the canonical NF-κB pathway in these cells. Previous studies using IKKβ knockout
mice demonstrate a clear phenotype similar to RelA knockout, suggesting that IKKβ causes
canonical NF-κB pathway activation [31, 32]. Although IKKα and IKKβ share structural and
biochemical similarities, different phenotypes in IKKα and IKKβ knockout mice imply
distinct physiological roles of the IKK isoforms [33]. They phosphorylate distinct substrates
in the cytoplasm and their sub-cellular distribution differs: IKKα can be detected in both the
cytoplasm and the nucleus whereas IKKβ is detected predominantly in the cytoplasm [34].
Studies of the nuclear role of IKKα provide evidences for the essential role of this kinase in
NF-κB-dependent transcription. Our results are also in accordance with earlier studies of the
roles of IKKα and IKKβ in other cellular models, such as chondrocytes and fibroblasts [35,
36], indicating that the differential requirements for IKK in regulating proteins can be an
extended process.
The addition of the proteasome inhibitor MG132 to the shIKKα condition prevented Smn
reduction. This finding suggests that proteasome activity may be increased in IKKα
knockdown cells, which could be the main reason for Smn decrease in this culture condition.
It has been previously reported that SMN protein degradation is mediated via the
ubiquitin/proteasome pathway, which regulates its cytoplasmic level [27]. In MNs, treatment
with proteasome inhibitors increases SMN protein level [37], suggesting that this degradation
pathway is involved in SMN stability in these neurons. Therefore, proteasome activity and
SMN level may constitute a key point in MN degeneration in SMA. Increased proteasome
activity can exacerbate SMN reduction, leading to deterioration in MN function.
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On the other hand, the effect of IKKβ knockdown on Smn level occurs through increased
Smn mRNA. Thus, the absence of IKKβ stimulates Smn transcription. One candidate to
produce this effect is CREB. Previous experiments described CREB protein binding to the
CRE-II site in the SMN promoter as positively regulating SMN expression, and treatment with
cAMP-elevating agents increased expression of both the full-length and exonΔ7SMN
transcript in HeLa cells [28]. Moreover, when activated in SMA spinal cords, CREB binding
to its response elements is significantly increased at the level of the SMN2 gene promoter and
is correlated with an increase in SMN expression [38]. We measured CREB protein level in
IKKα- and IKKβ-reduced cells, and our results showed the increase of CREB in shIKKβ
condition and the reduction of CREB in shIKKα. Furthermore, CREB-reduced cells showed a
slight, but significant, Smn decrease, indicating that CREB may be regulating SMN protein
level in MNs. In conclusion, our results are in accordance with previous reports describing
CREB involvement in SMN regulation.
The contribution of IKKs in neurodegenerative disorders has been proposed as a direct
interaction of the IKK complex with huntingtin [39] and as regulating the pathogenesis of
Huntington disease by inducing cleavage of mutated huntingtin [40]. IKKs phosphorylate
huntingtin residues, activating their clearance by proteasomes and lysosomes. SMN complex
and SMN itself can be phosphorylated in serine/threonine and lysine residues that regulate the
subcellular localization of the SMN complex and its accumulation into the nucleus [41]. PKA
can phosphorylate SMN, reducing its degradation in cultured cells [26]. These evidences may
lead to a further analysis of the role of SMN phosphorylation, proteasome degradation, and
NF-κB pathway. A comprehensive analysis of post-translational modifications such as
phosphorylation and increase of proteasome degradation can explain some of the events
involved in SMA pathogenesis and the specific vulnerability of spinal cord MNs to SMN
protein level. However, studies using SMA patient-derived fibroblasts have not detected
alterations in proteasome activity [26], suggesting that proteasome function in SMA patient
cells is preserved; nevertheless, pharmacological inhibition of proteasome activity, together
with an upregulation of SMN gene transcription, increases SMN levels and improves lifespan
of SMA mice [42, 43]. Additionally, treatment with sodium butyrate-based compounds
ameliorates SMA pathology, possibly by regulating intracellular pathways altered in SMN
deficiency and not by regulating SMN protein expression [44]. These observations should
help to further define the pathways and allow the identification of more specific targets for
therapeutic approaches.
Our results provide new evidences that the NF-κB pathway is modified in MNs of a mouse
SMA model. Changes in RelA protein levels were not statistically significant, but the
phosphorylation of RelA was reduced in SMA samples. Given recent results supporting the
hypothesis that the regulation of altered intracellular pathways may be the future
pharmacological treatment of SMA [44, 45], we propose the NF-κB pathway as a candidate
to this new therapeutic model.
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